A copy number variation morbidity map ofdevelopmental delay

To understand the genetic heterogeneity underlying developmental delay, we compared copy number variants (CNVs) in 15,767
children with intellectual disability and various congenital defects (cases) to CNVs in 8,329 unaffected adult controls. We
estimate that ~14.2% of disease in these children is caused by CNVs >400 kb. We observed a greater enrichment of CNVs in
individuals with craniofacial anomalies and cardiovascular defects compared to those with epilepsy or autism. We identified 59
pathogenic CNVs, including 14 new or previously weakly supported candidates, refined the critical interval for several genomic
disorders, such as the 17q21.31 microdeletion syndrome, and identified 940 candidate dosage-sensitive genes. We also
developed methods to opportunistically discover small, disruptive CNVs within the large and growing diagnostic array datasets.
This evolving CNV morbidity map, combined with exome and genome sequencing, will be critical for deciphering the genetic
basis of developmental delay, intellectual disability and autism spectrum disorders.

Author

Gregory M Cooper | Bradley P Coe | Santhosh Girirajan | Jill A Rosenfeld | Tiffany H Vu | Carl Baker | Charles Williams | Heather Stalker | Rizwan Hamid | Vickie Hannig | Hoda Abdel-Hamid | Patricia Bader | Elizabeth McCracken | Dmitriy Niyazov | Kathleen Leppig | Heidi Thiese | Marybeth Hummel | Nora Alexander | Jerome Gorski | Jennifer Kussmann | Vandana Shashi | Krys Johnson | Catherine Rehder | Blake C Ballif | Lisa G Shaffer | Evan E Eichler

The Project 8p Foundation (Project 8p) was created in 2018 to:

  • Accelerate future treatments, not only for 8p, but potentially for other chromosome-wide diseases as well.
  • Lead with knowledge from patients. Currently, there is no cure for 8p disorders, nor is there a standard course of treatment.

The Project 8p Foundation (Project 8p) was created in 2018 to:

  • Raise transformative funding for pioneering scientific research into treatments for a complex, rare disease involving 250+ affected genes on the short arm of the 8 th chromosome (8p). Rearrangements of these genes causes significant abnormalities to the entire neurological system, thus all organs and functions of the body– with variance in cognitive functions, gross motor skills, social development and other challenges during infancy, and throughout life;
  • Empower a unified community of 8p patients and their families so they can have meaningful lives today; and
  • Accelerate future treatments, not only for 8p, but potentially for other chromosome-wide diseases as well.